T. Del Ser

TL;DR: The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and pathologic diagnosis of DLB incorporating new information about the core clinical features and suggesting improved methods to assess them as mentioned in this paper.

TL;DR: The data demonstrate that the 3 rating scales studied reflect the actual volume of ARWMCs well and the visual assessment of ARwMC progression remains problematic and may require modifications or extensions of existing rating scales.

TL;DR: The development of the NINDS-AIREN criteria for vascular dementia have introduced a new application for these rating scales in investigating and delineating the amount of white matter changes on CT/MRI sufficient to fulfill the criteria.

TL;DR: Benefits to cognitive function were accompanied by a significant improvement of the other primary outcome measure, the Neuropsychiatric Inventory, three weeks after discontinuation of rivastigmine, most parameters of cognitive performance returned to predrug levels.

TL;DR: White matter changes in stroke patients are often associated with small-vessel disease and lead to a higher risk of death, and poor cardiac and neurological outcome, however, several questions remain open and need further investigations.